Expression of bovine papillomavirus (BPV) early gene products is required for viral DNA replication and establishment of the transformed phenotype. By the use of a highly efficient electroporation system, we have examined for the first time the transcriptional activity of BPV promoters in their natural genomic context in a replication-permissive cell line. We have determined that a qualitatively distinct stage of transcription is not detectable prior to DNA replication in transiently transfected cells. This suggests that the transcriptional activity of the BPV genome in stably transformed cells represents the early stage of BPV gene expression. Quantitative differences in promoter activity between transiently transfected and stably transformed cells suggest that subtle changes in gene expression may control progression of the viral life cycle. Deletion analysis demonstrated that the E2 transactivator protein stimulates all of the early promoters through sequences located in the upstream regulatory region. This E2-dependent enhancer was found to be highly redundant, and particular E2 binding sites did not display a preference for particular promoters. Despite this dependence on a common cis-acting sequence, the various promoters displayed different sensitivities to the E2 transactivator. The findings that E2 regulates all promoters and, with the exception of the E2 repressors, that no other known viral gene product appears to affect transcription indicate that the E2 system functions as the master regulator of BPV early gene expression.
The papillomaviruses are small DNA viruses that cause benign epithelial tumors (warts) in a variety of animal species and are sometimes associated with malignant carcinomas. Virus production is limited to terminally differentiated keratinocytes, and it has not yet been possible to propagate any of the papillomaviruses in a cell culture system (17) . Bovine papillomavirus (BPV) has been chosen as the prototype for the molecular and genetic analysis of the papillomaviruses because it transforms certain rodent cells in culture and persists as a multicopy nuclear episome (14, 22) , a state believed to be analogous to the latent infection of the basal epithelial cells and dermal fibroblasts of a fibropapilloma (17) . Gene expression is limited to the early region of the virus and results in low levels of viral mRNAs and proteins (17) .
One major transcription-regulatory system of BPV involves the interaction of the viral E2 gene products with enhancer elements in the upstream regulatory region (URR), also referred to as the long control region (9, 42) . The product of the E2 open reading frame (ORF) is a transcriptional activator that binds as a dimer (6, 27) to the sequence ACCN6GG/TT (1, 10, 23, 30, 31) , where N is any nucleotide.
There are 17 such sites in the BPV genome, 11 of which are located in the URR (23) . In addition to the transactivator protein, the E2 ORF encodes two repressor proteins: E2C (also called E2TR), which contains only the carboxy-terminal DNA-binding and dimerization domains of E2 (21) ; and E8/E2, which consists of the first 11 amino acids encoded by the E8 ORF fused to the carboxy-terminal domain of E2 (4, 11, 19) . The repressors are believed to function by competing with the transactivator homodimers for binding to DNA or by associating with the transactivator to form inactive heterodimers (21) . Displacement of cellular factors or the * Corresponding author.
formation of nonfunctional transcription complexes might also occur, as suggested by the finding that the E8/E2 protein can repress the basal activity of the P2 (P89) promoter (4) .
The E2 proteins are expressed from several different viral promoters. The E2C and E8/E2 repressors are expressed from the PS (P3080) and P3 (P89) promoters, respectively (4, 21) , and the E2 transactivator is expressed from the P2, P3, and P4(P2443) promoters (12, 33, 41, 49) . Since at least the P2 and P4 promoters have been shown to be regulated by the E2 activator and repressor proteins in a URR-dependent manner (8, 9, 12, 33, 40, 41) , it is possible that an autoregulatory circuit based on the E2 proteins is crucial for control of BPV gene expression. Indeed, it appears that a precise regulation of gene expression is necessary for control of BPV copy number, since mutations in the E2C repressor result in a high-copy-number phenotype in stably transformed cell lines (20, 34) . In addition, repressor mutants replicate to higher levels than the wild type in transient replication assays (47) .
To explore the regulatory circuit that controls the BPV life cycle, it is necessary to examine transcriptional regulation in the environment in which BPV is capable of replication, establishment and maintenance of an episomal state, and transformation. Mouse C127 cells have been the cell line of choice for the genetic analysis of BPV because transformed cells are easily recognizable by their morphology, thereby permitting quantitative focus assays (7) . The transcripts present in stably transformed cells have been examined in detail (2, 43, 51) , but the study of transcriptional regulation with this system is complicated by the indirect effects of engineered mutations on the viral life cycle. This limitation can be overcome by the use of transient expression experiments, in which mutations can be assayed for their direct effects on transcription.
In a previous report, we described the development of a highly efficient electroporation system and its use in a transient replication assay (46) . In this study we (28) . The 3-globin template pSP6,350 was described previously (13 (46) . To assay the activity of each promoter individually, we produced uniformly labeled RNA probes for use in RNase protection assays, which are sensitive enough to detect very low levels of mRNA.
The experiment shown in Fig. 1 demonstrates the feasibility of this approach. C127 cells were electroporated with 10 jig of pMLBPV, which contains the entire wild-type BPV genome cloned into a plasmid vector (25) RT in Fig. 1B . The BPV-specific probes were purposely designed to be quite short (Fig. 1B ) so as to avoid detection of splice donors and acceptors and minimize the number of bands on the gel. However, the P3 probe detects a splice donor at BPV nt 864, resulting in a protected fragment of 68 nt. The 3-globin probe protects a large region of its cognate message and produces three bands, representing correctly initiated P-globin RNA plus RNA initiated within the upstream vector sequences and spliced at cryptic sites (45) .
To determine the relative abundance of mRNAs initiating at the viral promoters, the intensity of the bands was quantitated with a Molecular Dynamics Phosphorlmager. The value obtained was normalized to that for the P-globin signal and then to the number of cytosine residues (the labeled nucleotide in the probe) in the protected fragment. We found that the pattern of relative message abundance was quantitatively different between the cells transiently transfected with pMLBPV and the stably transformed (VI216) cells (Table 1 ). The P2 promoter expressed the most mRNA in VI216 cells but not in the transfected cells. The level of P4-specific message was equal to that of P2 in the transfection but was lower than that of P2 in the stable transformants. Most strikingly, the level of mRNA expressed from the P3 and P5 promoters relative to that expressed from P2 was four-to sixfold lower in V1216 cells than in transiently transfected cells. It (44, 46) . The finding that replication-defective El mutants (46) display wild-type transcriptional activity (see Fig. 5 ) confirms that replication has a negligible effect on mRNA levels at 30 h posttransfection. Preliminary experiments suggest that no dramatic changes in the expression pattern occur from 2 through 5 days after the transfection (44), throughout which time DNA replication is proceeding (44, 46) . Therefore, the situation in stably transformed cells appears to represent the early stage of BPV gene expression, and a qualitatively distinct stage of transcription is not detectable prior to DNA replication in transiently transfected cells.
BPV early promoters display differential sensitivities to the E2 transactivator. To examine the effect of the E2 transactivator protein on expression from the intact genome, we cotransfected C127 cells with 10 jig of pMLBPV plus 2 ,ug of pHSE2, which expresses the full-length E2 protein from the heat shock protein 70 promoter. This vector has been shown by metabolic labeling and immunoprecipitation to express only full-length E2 (47) . The RNA initiating at the heat shock promoter of pHSE2 protects the entire P5 probe, but the expression from the P5 promoter within the E2 ORF is below the limit of detection (Fig. 1B, lane 7) . In addition, pHSE2 is incapable of expressing the E2C repressor due to a point mutation which changes the initiation codon for E2C from ATG to ATC. Expression of the E2 (17) . Specifically, two groups of sites, termed E2RE1 (sites 7 to 10) and E2RE2 (sites 1 and 2), were shown by CAT assays in CV-1 cells to be most important for E2-dependent enhancer activity (9, (39) (40) (41) . No deletion analysis of the activation of the P3 and P5 promoters has been performed. We therefore sought to determine whether the E2-dependent enhancer affects all the early promoters in their natural context in C127 cells and, if so, which sequences in the URR were responsible for the effect. We wished to determine whether all or only a subset of the E2 binding sites contribute to the induction and whether certain E2 binding sites might be selective for different promoters. Figure 3 shows a series of deletion mutations in the URR which were cloned into the pE2TTL background. The undeleted URR in pE2TTL is referred to as wild type in this experiment. No small deletion had a severe effect on expression from any promoter in either the presence or absence of E2 (Fig. 3B) 9, and 17) .
contrast, the 134/121 deletion, which affects only site 9, had no significant effect on any promoter. This suggests that site 10, which has the highest relative equilibrium binding constant of all the E2 binding sites (23) , may make the largest contribution to the overall E2 response.
Since the experiment in Fig. 3B indicated that no small region of the URR is absolutely required for basal or induced transcription, we constructed a series of plasmids unidirectionally deleted from the 5' end of the URR. We observed a stepwise loss of activity with increasing deletion size for all promoters (Fig. 3C) In the presence of E2, the constructs in Fig. 3D expressed a fairly constant amount of mRNA up to and including the Cla/221 deletion (lane 12), followed by a complete loss of E2 inducibility by the Nar/221 deletion (lanes 13 and 14) . This dramatic decrease in activity was in contrast to the generally steady decrease of activity observed in Fig. 3C . Deletion of the entire URR eliminated expression from P2, P3, and P4 even in the presence of E2, whereas P5 retained some activity but was no longer E2 inducible (lanes 15 (16, 29) and suggested by functional analysis (39) , perhaps E2 binding sites 1 to 4 were sufficient for full response in Fig. 3D (24, 41) . This raises the possibility that the E2 binding sites located near P4 (site 15) and P5 (sites 16 and 17) may act to direct the activity of E2 bound at the URR to these distal promoters.
We therefore chose to investigate the role of E2 binding sites 15, 16, and 17 in the context of the viral genome by mutating these sites and assaying expression from P4 and P5.
In Fig. 4 20 ,ug of total plasmid DNA plus carrier. Cytoplasmic RNA was extracted at 30 h posttransfection, divided into aliquots, and hybridized to P-globin probe plus probes specific for P2 plus P4 or P5, as indicated. Basal levels of P2 and P4 are visible on long exposures and are quantifiable by the Phosphorlmager. presence of E2, the level of P4 messages was reduced slightly by a 1-bp deletion (pSitelSAl) and severalfold by a 5-bp deletion (pSitel5A5). The Al and A5 mutations change the sequence of the second half of the palindromic binding site from GGT to GTA and GCA, respectively. The levels of P2 and P5 messages were wild type, indicating that the effect of the site 15 mutations is specific to the P4 promoter. The major effect, however, was a reduction in the basal levels of the mutants, which was detectable on long exposures. The site 15 mutants are still highly responsive to E2, albeit to a lower level than the wild type. We conclude that although binding site 15 is not absolutely required for E2 activation of the P4 promoter, it appears that this site, or more likely the sequences adjacent to it, plays at least some role in the response.
Similar results were obtained upon mutation of the E2 binding sites near the P5 promoter. Although the site 17 mutation had no effect on the basal or induced activity of P5 or any other promoter, the site 16/17 double mutant reduced P5 basal expression by about 50%. The fold induction by E2 remained at wild-type levels, however, indicating that binding sites 16 and 17 are not involved in the response of the P5 promoter to the E2 protein and that the point mutation within E2 binding site 16 most likely affects a basal promoter element.
The El, E6, and E6/7 gene products do not function as transcriptional regulators. Since pE2TTL is capable of expressing all documented BPV early gene products except the E2 proteins, it was necessary to determine whether the stimulatory effect of E2 on all promoters is direct or is mediated by a viral gene product that is expressed in response to E2. The investigation of El function is of particular interest, since it has been observed that El mutants display elevated P2 activity in stably transformed cell lines (18, 37) . It was suggested that the El protein might repress transcription from the P2 promoter or that the increased P2 activity might be an indirect effect of the state of the viral DNA in cells transformed with wild-type BPV or 6) . The transfection mix for lane 7 was the same except that it contained no BPV test plasmid. Cytoplasmic RNA was extracted at 30 h posttransfection, divided into aliquots, and hybridized to P-globin probe plus probes specific for P2 plus P4, P3, or P5, as indicated.
El mutants, which are present in episomal and integrated states, respectively (18, 37) . We decided to test this hypothesis directly by assaying the transcriptional activity of El mutants. We mutated the El ORF either by placing a translation termination linker at the SmaI site (SmaTTL) or by deleting the 296 bp between the BgIII and BclI sites (ABgl/Bcl), which also creates a frameshift mutation. By comparing RNA from C127 cells transfected with wild-type and El mutant constructs, we found that the level of RNA expressed from the P2 promoter was unaffected by either mutation of the El ORF (Fig. 5, lanes 1, 3, and 5 ). Expression from the P3, P4, and P5 promoters was also unaffected by the El mutations, suggesting that the El gene product does not play a role in transcriptional regulation.
Since it is possible that insufficient El protein is expressed from pMLBPV to produce a detectable effect in a transient transfection, we thought it important to employ an expression vector to achieve much higher intracellular levels of El.
The plasmid pCGEag has been shown to express full-length El protein and is able to complement an El mutation in a transient replication assay (46) . We cotransfected the wildtype and El mutant plasmids with pCGEag and found that the El expression vector had no effect on expression from the P2 and P5 promoters (Fig. 5) . The effect of pCGEag on P3 and P4 was difficult to determine because of the large amount of mRNA from the expression vector. Therefore, the El protein does not appear to possess a transcriptional regulatory function, and in particular, it does not repress the activity of the P2 promoter. It is therefore more likely that the effect observed in previous studies (18, 37) was due to an indirect effect of the inability of the El mutants to replicate episomally.
We also assayed the transcriptional activity of pMLBPV constructs which contained mutations in the E6 or E7 ORF. The 775 (E6) and 576 (E6/7) mutants, which were described previously (3), displayed wild-type mRNA levels, consistent with previous experiments with stably transformed cell lines (32) . Cotransfection with plasmids which express the E6 or E6/7 protein similarly had no effect (data not shown). Lastly, the mutations in the El, E6, and E6/7 ORFs were also assayed in the pE2TTL background and were found to have no effect on the ability of any promoter to respond to E2 (data not shown). (15, 19) . Although the level of the E2C repressor is presumably initially high upon viral infection, the P2 and P4 promoters have a low but significant basal activity. At least a portion of the messages that initiate at these promoters code for the E2 transactivator (12, 33, 41, 49) . That some transactivator is indeed expressed early after infection is suggested by the higher basal activity of pMLBPV than of pE2TTL. Based on the E2 titration, the level of E2 activity in the wild-type transfection is roughly equivalent to that produced by about 100 to 200 ng of the E2 expression vector. Expression of this small amount of E2 early after infection would specifically activate the P2 and P4 promoters. Since the P5 promoter would not be concomitantly stimulated, synthesis of the E2C repressor would not keep pace with that of the E2 activator. This would result in a strong positive autoregulation of E2 transactivator expression. Autoregulation of E2 expression from the P4 promoter has also been suggested by Hermonat et al. (12) . In response to the rising E2 activator levels, expression of the E5 protein from the P4 promoter (2, 11, 33, 41) would increase dramatically, resulting in cellular transformation. Production of the E6 protein, which is also involved in transformation and is believed to be expressed from the P2 promoter (17) , would also be increased.
DISCUSSION
A significantly lower level of messages is expressed from the P3 promoter in transformed cells than in the short-term assay, suggesting that P3 may be specifically downregulated during the course of the viral infection. It is unclear what the role of the P3 promoter might be, however, since P3 is the weakest promoter under any circumstance and appears to express both the E2 activator (49) and the E8/E2 repressor (4). Perhaps this promoter supplies some sort of back-up system, as suggested by the finding that an E8/E2 mutant is phenotypically normal, whereas mutations that inactivate E8/E2 and E2C have a more severe effect than a mutation that affects E2C only (20) . The E2 titration, while informative, clearly represents only part of the BPV gene expression program. The situation in stably transformed cells or in an actual viral infection is more complicated, since the repressors are also present. Perhaps BPV promoters also display differential sensitivities to the repressors to arrive at the pattern of promoter activity that is seen in transformed cells. This could explain why the level of P3-specific messages relative to P2-specific messages is considerably lower in transformed cells than in the shortterm assay, even though the P2 and P3 promoters are equally sensitive to the E2 activator.
It is important to note that the differential sensitivities of the promoters to the E2 transactivator are not due simply to distance effects or a gradient of enhancer activity, since P4 responds to a greater degree than P2 and P3, which are much closer to the E2 enhancer. Therefore, the question arises as to what does determine the degree of sensitivity to the E2 transactivator. It has been recently shown that transcription factor Spl is important for the basal activity of the P4 and P5 promoters (24, 41) and physically interacts with the E2 transactivator to mediate their induction (24) . Perhaps E2 can also interact with other cellular factors so that the number, arrangement, and type of factors that are bound at a given BPV promoter determine how well it responds to E2. The effect of the binding site 15 Al and A5 mutations suggests that in addition to the Spl site, other sequence elements upstream from the P4 promoter may be involved in the response to E2. These mutations delete only the downstream end of site 15 and therefore do not affect the Spl site. It is possible that the deletions affect some other promoter element which overlaps the downstream end of site 15 , resulting in a decrease in activity. The mutations might also bring binding sites for cellular factors closer together, causing steric hindrance. This could explain the more severe effect of the larger A5 deletion than of the Al deletion.
The deletion analysis presented in Fig. 3 showed that the E2-dependent enhancer of the URR activates transcription from all promoters and that all the E2 binding sites contribute to the effect. Previous reports have stated that sites 7 to 10 (referred to as E2RE1) were sufficient for full induced activity of P2 and P4 (9, 41) . In our system, however, the mutant containing these sites plus site 11 (234/11) retained only 15 to 30% of the wild-type activity. Similarly, we found that E2 binding sites 1 and 2 (referred to as E2RE2) (40) were no more important than any other pair of binding sites.
The URR also contains several basal transcription elements. The 36/221 deletion defines an element specific for P2 promoter activity. Basal elements that regulate all promoters are located between nt 6958 and 7388, a region that contains the constitutive enhancers described by two other groups (38, 50) . The first group defined an enhancer within nt 7215 to 7351 that weakly activated the simian virus 40 promoter in C127 cells (38) . The second group defined an enhancer within nt 7162 to 7275 that strongly activated transcription from the simian virus 40 early promoter but not from P2 in primary bovine fibroblasts (50) . Since the former enhancer does not contain the minimal functional element of the latter enhancer, the two were thought to be different (50) . The effect of the 234/Sca deletion (nt 7187 to 7389) is more in line with weak effects of the nt 7215 to 7351 enhancer than the strong effects of the nt 7162 to 7275 enhancer. This could be due to cell type specificity, since the latter enhancer displayed weak activity in C127 cells (50) .
It is of interest to determine how the progression of the viral life cycle is regulated from infection by a single virion to stable maintenance of about 100 copies of the viral DNA per cell. Based on our results, changes in BPV gene expression during the establishment of stable copy number are most likely quantitative and subtle. In addition to transcriptional control, regulation of RNA splicing, transport, and stability, translational control, and posttranslational modifications may also play a role in the BPV life cycle. We find it remarkable that BPV can establish and maintain itself in cultured cells with only subtle alterations in its gene expression pattern. The findings that El and E2 are required for short-term BPV replication (46) and that E2 is continuously required for viral DNA replication in stably transformed cells (5) suggest that viral gene expression controls DNA replication under all circumstances. Therefore, it seems probable that maintenance of BPV as a multicopy episome over numerous generations requires a finely tuned regulatory system. It has been shown that mutation of one form of E2 affects the level of the other forms and that E2 repressor mutants display a high-copy-number phenotype (19, 20, 34) . These findings, together with our results that all promoters respond to the E2 activator through the URR and that no other BPV gene products are involved, suggest that viral homeostasis could be maintained by a delicate balance between the E2 activator and repressor proteins.
